adeno-associated viral with human factor ix
Gene therapyexperimental
Clinical trial activity
1 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2004 (NCT00076557)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Coagulation factor IXSupplementation
F9 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- adeno-associated viral with human factor ix
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00076557 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2004 | Avigen, Christian Medical College, Vellore, India, Stanford University, University of Campinas, University of Pennsylvania, University of Pittsburgh, University of Sydney, University of Texas at Houston, University of Washington |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Avigen | For profit | 1 | 1 | 1 | 2004 |
| Christian Medical College, Vellore, India | Academic/Hospital | 1 | 0 | 1 | 2004 |
| Stanford University | Academic/Hospital | 1 | 0 | 1 | 2004 |
| University of Campinas | Academic/Hospital | 1 | 0 | 1 | 2004 |
| University of Pennsylvania | Academic/Hospital | 1 | 0 | 1 | 2004 |
| University of Pittsburgh | Academic/Hospital | 1 | 0 | 1 | 2004 |
| University of Sydney | Academic/Hospital | 1 | 0 | 1 | 2004 |
| University of Texas at Houston | Academic/Hospital | 1 | 0 | 1 | 2004 |
| University of Washington | Academic/Hospital | 1 | 0 | 1 | 2004 |
9 organizations
Page 1 / 1